These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 27083831)

  • 1. Thermosensitive chitosan-based hydrogel as a topical ocular drug delivery system of latanoprost for glaucoma treatment.
    Cheng YH; Tsai TH; Jhan YY; Chiu AW; Tsai KL; Chien CS; Chiou SH; Liu CJ
    Carbohydr Polym; 2016 Jun; 144():390-9. PubMed ID: 27083831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sustained delivery of latanoprost by thermosensitive chitosan-gelatin-based hydrogel for controlling ocular hypertension.
    Cheng YH; Hung KH; Tsai TH; Lee CJ; Ku RY; Chiu AW; Chiou SH; Liu CJ
    Acta Biomater; 2014 Oct; 10(10):4360-6. PubMed ID: 24914827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thermosensitive chitosan-gelatin-based hydrogel containing curcumin-loaded nanoparticles and latanoprost as a dual-drug delivery system for glaucoma treatment.
    Cheng YH; Ko YC; Chang YF; Huang SH; Liu CJ
    Exp Eye Res; 2019 Feb; 179():179-187. PubMed ID: 30471279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of latanoprost-loaded biodegradable nanosheet as a new drug delivery system for glaucoma.
    Kashiwagi K; Ito K; Haniuda H; Ohtsubo S; Takeoka S
    Invest Ophthalmol Vis Sci; 2013 Aug; 54(8):5629-37. PubMed ID: 23868986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained release of an anti-glaucoma drug: demonstration of efficacy of a liposomal formulation in the rabbit eye.
    Natarajan JV; Chattopadhyay S; Ang M; Darwitan A; Foo S; Zhen M; Koo M; Wong TT; Venkatraman SS
    PLoS One; 2011; 6(9):e24513. PubMed ID: 21931735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of 15-keto latanoprost on intraocular pressure and aqueous humor dynamics in monkey eyes.
    Wang RF; Gagliuso DJ; Mittag TW; Podos SM
    Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4143-7. PubMed ID: 17724199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ocular hypotensive activity of BOL-303259-X, a nitric oxide donating prostaglandin F2α agonist, in preclinical models.
    Krauss AH; Impagnatiello F; Toris CB; Gale DC; Prasanna G; Borghi V; Chiroli V; Chong WK; Carreiro ST; Ongini E
    Exp Eye Res; 2011 Sep; 93(3):250-5. PubMed ID: 21396362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chitosan-Gelatin Hydrogel Crosslinked With Oxidized Sucrose for the Ocular Delivery of Timolol Maleate.
    El-Feky GS; Zayed GM; Elshaier YAMM; Alsharif FM
    J Pharm Sci; 2018 Dec; 107(12):3098-3104. PubMed ID: 30165067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Montmorillonite/chitosan nanoparticles as a novel controlled-release topical ophthalmic delivery system for the treatment of glaucoma.
    Li J; Tian S; Tao Q; Zhao Y; Gui R; Yang F; Zang L; Chen Y; Ping Q; Hou D
    Int J Nanomedicine; 2018; 13():3975-3987. PubMed ID: 30022821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A temperature-induced and shear-reversible assembly of latanoprost-loaded amphiphilic chitosan colloids: characterization and in vivo glaucoma treatment.
    Hsiao MH; Chiou SH; Larsson M; Hung KH; Wang YL; Liu CJ; Liu DM
    Acta Biomater; 2014 Jul; 10(7):3188-96. PubMed ID: 24681374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanomedicine for glaucoma: liposomes provide sustained release of latanoprost in the eye.
    Natarajan JV; Ang M; Darwitan A; Chattopadhyay S; Wong TT; Venkatraman SS
    Int J Nanomedicine; 2012; 7():123-31. PubMed ID: 22275828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel nitric oxide releasing prostaglandin analog, NCX 125, reduces intraocular pressure in rabbit, dog, and primate models of glaucoma.
    Borghi V; Bastia E; Guzzetta M; Chiroli V; Toris CB; Batugo MR; Carreiro ST; Chong WK; Gale DC; Kucera DJ; Jia L; Prasanna G; Ongini E; Krauss AH; Impagnatiello F
    J Ocul Pharmacol Ther; 2010 Apr; 26(2):125-32. PubMed ID: 20415621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo performance of a drug-eluting contact lens to treat glaucoma for a month.
    Ciolino JB; Stefanescu CF; Ross AE; Salvador-Culla B; Cortez P; Ford EM; Wymbs KA; Sprague SL; Mascoop DR; Rudina SS; Trauger SA; Cade F; Kohane DS
    Biomaterials; 2014 Jan; 35(1):432-9. PubMed ID: 24094935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of self-assembling system and N,O-carboxymethyl chitosan improves ocular residence of anti-glaucoma drug.
    Kailasam V; Kumara BN; Prasad KS; Nirmal J
    Eur J Pharm Biopharm; 2024 Apr; 197():114208. PubMed ID: 38336235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In situ formation of injectable chitosan-gelatin hydrogels through double crosslinking for sustained intraocular drug delivery.
    Song Y; Nagai N; Saijo S; Kaji H; Nishizawa M; Abe T
    Mater Sci Eng C Mater Biol Appl; 2018 Jul; 88():1-12. PubMed ID: 29636124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A triple crosslinked micelle-hydrogel lacrimal implant for localized and prolonged therapy of glaucoma.
    Zhao J; Xiong J; Ning Y; Zhao J; Wang Z; Long L; He H; Gou J; Yin T; Tang X; Zhang Y
    Eur J Pharm Biopharm; 2023 Apr; 185():44-54. PubMed ID: 36841507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ocular effects of prostaglandins and the therapeutic potential of a new PGF2 alpha analog, PhXA41 (latanoprost), for glaucoma management.
    Bito LZ; Stjernschantz J; Resul B; Miranda OC; Basu S
    J Lipid Mediat; 1993; 6(1-3):535-43. PubMed ID: 8358014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of latanoprost when stored at room temperature.
    Mochizuki H; Itakura H; Takamatsu M; Kiuchi Y
    Hiroshima J Med Sci; 2008 Jun; 57(2):69-72. PubMed ID: 18717189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment merits of Latanoprost/Thymoquinone - Encapsulated liposome for glaucomatus rabbits.
    Fahmy HM; Saad EAES; Sabra NM; El-Gohary AA; Mohamed FF; Gaber MH
    Int J Pharm; 2018 Sep; 548(1):597-608. PubMed ID: 29997042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chitosan nanoparticles amplify the ocular hypotensive effect of cateolol in rabbits.
    Ameeduzzafar ; Ali J; Bhatnagar A; Kumar N; Ali A
    Int J Biol Macromol; 2014 Apr; 65():479-91. PubMed ID: 24530326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.